Bioclinica, a provider of technology-enabled solutions for clinical research, launched Bioclinica Clinical Adjudication, a transformational offering in which medical specialists and researchers, backed by advanced technology, lead independent Clinical Event Committee (CEC) review. The new service enables the independent adjudication of clinical events in conformance with regulatory requirements governing clinical trials within all therapeutic areas, including cardiac studies and for Major Adverse Cardiac Events (MACE) committees.
FDA announces approval of first breakthrough-designated test
Certara launches Version 17 of its PBPK Simcyp Simulator
The Pulse on Site Success by Christophe Berthoux
Advancements in clinical research with the adoption of evolving technology has brought many new opportunities to patient recruitment. The industry is experiencing considerable trends that are changing the way researchers find, screen and retain patients. These developments, such as the ability to geotarget specific regions or monitor real-time data, have led to increased efficiency in identifying patients.